These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5565254)

  • 21. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M; Alvarez C; Herlin S
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of fluphenazine enanthate and fluphenazine decanoate on discriminated avoidance response and water drinking behavior in rats.
    Kuribara H; Tadokoro S
    Psychopharmacology (Berl); 1979 Sep; 65(1):1-6. PubMed ID: 116283
    [No Abstract]   [Full Text] [Related]  

  • 23. Depot fluphenazine enanthate and decanoate: comparative rates of release in dogs.
    Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
    J Pharm Pharmacol; 1975 Oct; 27(10):791-2. PubMed ID: 241800
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of accumulation of fluphenazine enanthate and fluphenazine decanoate, long-acting neuroleptic drugs, after repeated administrations by means of their inhibitory effects on the discriminated avoidance response in rats.
    Kuribara H; Tadokoro S
    J Toxicol Sci; 1979 May; 4(2):87-98. PubMed ID: 501762
    [No Abstract]   [Full Text] [Related]  

  • 25. Controlled trial of depot fluphenazine in out-patient schizophrenics.
    Crawford R; Forrest A
    Br J Psychiatry; 1974 Apr; 124(0):385-91. PubMed ID: 4599422
    [No Abstract]   [Full Text] [Related]  

  • 26. Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
    Yamada K; Furukawa T
    Pharmacology; 1982; 24(3):147-55. PubMed ID: 7200248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prolonged action of fluphenazine enanthate in oil after depot injection.
    Laffan RJ; High JP; Burke JC
    Int J Neuropsychiatry; 1965 Aug; 1(4):300-6. PubMed ID: 5863505
    [No Abstract]   [Full Text] [Related]  

  • 28. A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
    Johnson DA; Malik NA
    Acta Psychiatr Scand; 1975 May; 51(4):257-67. PubMed ID: 1096536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind trial of fluphenazine decanoate.
    Curry SH; Adamson L
    Lancet; 1972 Sep; 2(7776):543-4. PubMed ID: 4115602
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of resistant schizophrenics with extreme high dosage fluphenazine hydrochloride.
    Itil T; Keskiner A; Heinemann L; Han T; Gannon P; Hsu W
    Psychosomatics; 1970; 11(5):456-63. PubMed ID: 4919176
    [No Abstract]   [Full Text] [Related]  

  • 31. [Electroencephalographic effects of fluphonazine decanoate].
    Borenstein P; Cujo P; Dumaine A
    Ann Med Psychol (Paris); 1970 Jul; 2(2):273-5. PubMed ID: 5475414
    [No Abstract]   [Full Text] [Related]  

  • 32. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital computer analyzed sleep and resting EEG during haloperidol treatment.
    Itil TM; Gannon P; Hsu W; Klingenberg H
    Am J Psychiatry; 1970 Oct; 127(4):462-71. PubMed ID: 4318894
    [No Abstract]   [Full Text] [Related]  

  • 34. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
    Cookson JC; Kennedy NM; Gribbon D
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of pipothiazine palmitate and fluphenazine decanoate in the maintenance of remission of schizophrenia.
    Leong OK; Wong KE; Tay WK; Gill RC
    Singapore Med J; 1989 Oct; 30(5):436-40. PubMed ID: 2575796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs.
    Dreyfuss J; Ross JJ; Shaw JM; Miller I; Schreiber EC
    J Pharm Sci; 1976 Apr; 65(4):502-507. PubMed ID: 1271246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J; Villiger J; Hunter L
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community.
    Stevens BC
    Psychol Med; 1973 May; 3(2):141-58. PubMed ID: 4577254
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
    Wistedt B
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.